Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05534854
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:36.749745+00:00
Published At
2023-08-31T00:00:00+00:00
Record Updated At
2023-08-31
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Renal Tumor Histology", "Kidney Cancer", "Renal Cell Carcinoma", "Familial Renal Cancer", "HLRCC", "VHL Syndrome", "BAP1 Tumor Predisposition Syndrome", "FLCN Gene Mutation", "ALK Gene Mutation", "FH Gene Mutation", "Birt-Hogg-Dube Syndrome", "MET Gene Mutation", "Cutaneous Leiomyoma", "Cutaneous Leiomyomata With Uterine Leiomyomata"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-08-31"
protocolSection.identificationModule.nctId
"NCT05534854"
protocolSection.identificationModule.officialTitle
"Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Renal Tumor Histology (protocolSection.conditionsModule.conditions)
  • Kidney Cancer (protocolSection.conditionsModule.conditions)
  • Renal Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Familial Renal Cancer (protocolSection.conditionsModule.conditions)
  • HLRCC (protocolSection.conditionsModule.conditions)
  • VHL Syndrome (protocolSection.conditionsModule.conditions)
  • BAP1 Tumor Predisposition Syndrome (protocolSection.conditionsModule.conditions)
  • FLCN Gene Mutation (protocolSection.conditionsModule.conditions)
  • ALK Gene Mutation (protocolSection.conditionsModule.conditions)
  • FH Gene Mutation (protocolSection.conditionsModule.conditions)
  • Birt-Hogg-Dube Syndrome (protocolSection.conditionsModule.conditions)
  • MET Gene Mutation (protocolSection.conditionsModule.conditions)
  • Cutaneous Leiomyoma (protocolSection.conditionsModule.conditions)
  • Cutaneous Leiomyomata With Uterine Leiomyomata (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.